Free Trial

Clarke Murphy Analyst Performance

Analyst at Truist Financial

Clarke Murphy is a stock analyst at Truist Financial in the medical sector, covering 1 publicly traded companies. Over the past year, Clarke Murphy has issued 2 stock ratings, including strong buy and buy recommendations. While full access to Clarke Murphy's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Clarke Murphy's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
2 Last 0 Years
Buy Recommendations
100.00% 2 Buy Ratings
Companies Covered
1 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy50.0%1 ratings
Buy50.0%1 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

Out of 2 total stock ratings issued by Clarke Murphy at Truist Financial, the majority (50.0%) have been Strong Buy recommendations, followed by 50.0% Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
1 company

Clarke Murphy, an analyst at Truist Financial, currently covers 1 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
1 company
100.0%

Clarke Murphy of Truist Financial specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - OUTP/HM CRE
1 company
100.0%

Clarke Murphy's Ratings History at Truist Financial

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
1/7/2026Set Price Target$110.98$135.00Buy
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
1/7/2026Upgrade$112.33Strong-Buy